- $99.43bn
- $118.21bn
- £31.38bn
- 92
- 66
- 99
- 98
REG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Block listing Interim Review
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - MenABCWY vaccine preliminary phase III results
AnnouncementREG - GSK PLC - Statement: Zantac Litigation Update BC Canada
AnnouncementREG - GSK PLC - GSK completes sale of shares in Haleon plc
AnnouncementREG - GSK PLC - GSK announces intention to sell shares in Haleon
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Result of AGM
AnnouncementREG - GSK PLC - US FDA approves GSK’s RSV vaccine for older adults
AnnouncementREG - GSK PLC Allergy Therapeutics - Form 8.3 - Allergy Therapeutics plc
AnnouncementRCS - Harte Hanks, Inc - Harte Hanks Reports 2023 First Quarter Results
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementRCS - Envision Pharma Grp - Envision Pharma Group Appoints Mike Glover to SVP
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement